Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor las… Read more
Lotus Eye Hospital and Institute Limited (LOTUSEYE) - Total Assets
Latest total assets as of September 2025: ₹715.15 Million INR
Based on the latest financial reports, Lotus Eye Hospital and Institute Limited (LOTUSEYE) holds total assets worth ₹715.15 Million INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Lotus Eye Hospital and Institute Limited - Total Assets Trend (2007–2025)
This chart illustrates how Lotus Eye Hospital and Institute Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Lotus Eye Hospital and Institute Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Lotus Eye Hospital and Institute Limited's total assets of ₹715.15 Million consist of 16.6% current assets and 83.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹41.51 Million | 2.9% |
| Accounts Receivable | ₹13.23 Million | 1.9% |
| Inventory | ₹38.30 Million | 5.5% |
| Property, Plant & Equipment | ₹539.42 Million | 77.5% |
| Intangible Assets | ₹1.30 Million | 0.2% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Lotus Eye Hospital and Institute Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lotus Eye Hospital and Institute Limited's current assets represent 16.6% of total assets in 2025, a decrease from 24.7% in 2007.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, up from 0.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is property, plant & equipment at 77.5% of total assets.
Lotus Eye Hospital and Institute Limited Competitors by Total Assets
Key competitors of Lotus Eye Hospital and Institute Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Lotus Eye Hospital and Institute Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Lotus Eye Hospital and Institute Limited generates 0.71x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Lotus Eye Hospital and Institute Limited generates $ 1.06 in net profit.
Lotus Eye Hospital and Institute Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.40 | 1.52 | 1.85 |
| Quick Ratio | 0.90 | 1.02 | 1.55 |
| Cash Ratio | 0.44 | 0.59 | 0.00 |
| Working Capital | ₹29.89 Million | ₹ 40.27 Million | ₹ 50.40 Million |
Lotus Eye Hospital and Institute Limited - Advanced Valuation Insights
This section examines the relationship between Lotus Eye Hospital and Institute Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.21 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 4.4% |
| Total Assets | ₹695.74 Million |
| Market Capitalization | $7.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Lotus Eye Hospital and Institute Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Lotus Eye Hospital and Institute Limited's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Lotus Eye Hospital and Institute Limited (2007–2025)
The table below shows the annual total assets of Lotus Eye Hospital and Institute Limited from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹695.74 Million | +4.42% |
| 2024-03-31 | ₹666.27 Million | +5.44% |
| 2023-03-31 | ₹631.88 Million | +2.58% |
| 2022-03-31 | ₹615.97 Million | +4.00% |
| 2021-03-31 | ₹592.29 Million | +1.93% |
| 2020-03-31 | ₹581.06 Million | +2.57% |
| 2019-03-31 | ₹566.50 Million | -2.68% |
| 2018-03-31 | ₹582.12 Million | +5.96% |
| 2017-03-31 | ₹549.37 Million | +0.20% |
| 2016-03-31 | ₹548.29 Million | -2.81% |
| 2015-03-31 | ₹564.15 Million | -3.65% |
| 2014-03-31 | ₹585.54 Million | +2.91% |
| 2013-03-31 | ₹568.96 Million | +1.51% |
| 2012-03-31 | ₹560.49 Million | -10.48% |
| 2011-03-31 | ₹626.13 Million | +10.57% |
| 2010-03-31 | ₹566.27 Million | -8.79% |
| 2009-03-31 | ₹620.87 Million | +123.31% |
| 2008-03-31 | ₹278.03 Million | +17.04% |
| 2007-03-31 | ₹237.54 Million | -- |